Litcius/Paper detail

Early Antipsychotic Nonresponse as a Predictor of Nonresponse and Nonremission in Adolescents With Psychosis Treated With Aripiprazole or Quetiapine: Results From the TEA Trial

Anne Katrine Pagsberg, Amanda Krogmann, Pia Jeppesen, Laura von Hardenberg, Dea Gowers Klauber, Karsten Gjessing Jensen, Ditte Rudå, Marie Stentebjerg Decara, Jens Richardt Møllegaard Jepsen, Birgitte Fagerlund, Anders Fink‐Jensen, Christoph U. Correll, Britta Galling

2022Journal of the American Academy of Child & Adolescent Psychiatry23 citationsDOI

Topics & Concepts

AripiprazoleQuetiapinePsychosisAntipsychoticMedicinePsychiatrySchizophrenia (object-oriented programming)PsychologyPediatricsSchizophrenia research and treatmentBipolar Disorder and TreatmentTreatment of Major Depression
Early Antipsychotic Nonresponse as a Predictor of Nonresponse and Nonremission in Adolescents With Psychosis Treated With Aripiprazole or Quetiapine: Results From the TEA Trial | Litcius